17 ottob 2014 anni - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Aggiunto al nastro di tempo:
Data:
17 ottob 2014 anni
Adesso
~ 9 years and 7 months ago
